To evaluate the effectiveness of the trivalent mucosal vaccine in preventing Tf-, Pg-, and Fn-mediated alveolar bone loss, we performed a series of experiments combining intranasal vaccination and a LigR + OI challenge. This evidence concerns the gene FN1 and osteogenesis imperfecta.